Alopecia epidemiology and demographics: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 14: Line 14:
* Tinea capitis has a higher incidence among the pediatric age group and in darker races. <ref name="pmid30511475">Owczarczyk-Saczonek A, Wygonowska E, Budkiewicz M, Placek W (2019) [https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=30511475 Serum sickness disease in a patient with alopecia areata and Meniere' disease after PRP procedure.] ''Dermatol Ther'' 32 (2):e12798. [http://dx.doi.org/10.1111/dth.12798 DOI:10.1111/dth.12798] PMID: [https://pubmed.gov/30511475 30511475]</ref>
* Tinea capitis has a higher incidence among the pediatric age group and in darker races. <ref name="pmid30511475">Owczarczyk-Saczonek A, Wygonowska E, Budkiewicz M, Placek W (2019) [https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=30511475 Serum sickness disease in a patient with alopecia areata and Meniere' disease after PRP procedure.] ''Dermatol Ther'' 32 (2):e12798. [http://dx.doi.org/10.1111/dth.12798 DOI:10.1111/dth.12798] PMID: [https://pubmed.gov/30511475 30511475]</ref>
* Anagen effluvium is more common in cancer patients receiving treatment with chemotherapeutic agents.
* Anagen effluvium is more common in cancer patients receiving treatment with chemotherapeutic agents.
* Traction alopecia is more commonly seen among black populations with females being affected more often than males (31.7% vs 2.3). Traction alopecia was seen in 18% of girls between the ages of 5.4 to 14.3 years based on a study of African-American girls. An 8-month old girl was the youngest reported case in the study. <ref name="pmid29265342">{{cite journal| author=Aguado Lobo M, Jiménez-Reyes J| title=Traction alopecia. | journal=Int J Dermatol | year= 2018 | volume= 57 | issue= 2 | pages= 231-232 | pmid=29265342 | doi=10.1111/ijd.13846 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=29265342  }} </ref>


===Prevalence===
===Prevalence===
Line 27: Line 28:
**In ____ (insert year), the prevalence of _______ (insert disease name) was estimated to be _______ (insert number) cases per 100,000 individuals worldwide.
**In ____ (insert year), the prevalence of _______ (insert disease name) was estimated to be _______ (insert number) cases per 100,000 individuals worldwide.
===Incidence===
===Incidence===
* Incidence is defined as the number of new cases per population in a given time period.
* The overall incidence is approximately 20.2 per 100,000 person-years. <ref name="pmid7791384">{{cite journal| author=Safavi KH, Muller SA, Suman VJ, Moshell AN, Melton LJ| title=Incidence of alopecia areata in Olmsted County, Minnesota, 1975 through 1989. | journal=Mayo Clin Proc | year= 1995 | volume= 70 | issue= 7 | pages= 628-33 | pmid=7791384 | doi=10.4065/70.7.628 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=7791384  }} </ref>
*The standard format to report the incidence is ___ per 100,000 individuals.
*The standard format to report the incidence is ___ per 100,000 individuals.
*When using numbers with decimal points, avoid reporting more than 1 number after the decimal point. For example, report a incidence as 10.1 instead of 10.09322. Many numbers after the decimal point may suggest a false sense of accuracy.
*When using numbers with decimal points, avoid reporting more than 1 number after the decimal point. For example, report a incidence as 10.1 instead of 10.09322. Many numbers after the decimal point may suggest a false sense of accuracy.
Line 70: Line 71:
*There is no racial predilection for ____ (insert disease name)
*There is no racial predilection for ____ (insert disease name)
* _____ (insert disease) usually affects individuals of the _____ (insert race) race. _____ (insert other race) individuals are less likely to develop ______ (disease name).
* _____ (insert disease) usually affects individuals of the _____ (insert race) race. _____ (insert other race) individuals are less likely to develop ______ (disease name).
===Developed Countries===
* In this section you should describe the impact of the disease in developed countries.
* Incidence, prevalence, and geographical distribution or areas of interest can be mentioned, as well as the relevant impact the disease has on society.
===Developing Countries===
* In this section you should describe the impact of the disease in developing countries.
* Incidence, prevalence, and geographical distribution or areas of interest can be mentioned, as well as the relevant impact the disease has on society.


==References==
==References==

Revision as of 07:39, 30 December 2020

Alopecia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Alopecia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT Scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Laser Therapy

Concealing Hair Loss

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Alopecia epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Alopecia epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Alopecia epidemiology and demographics

CDC on Alopecia epidemiology and demographics

Alopecia epidemiology and demographics in the news

Blogs on Alopecia epidemiology and demographics

Directions to Hospitals Treating Alopecia

Risk calculators and risk factors for Alopecia epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ogechukwu Hannah Nnabude, MD

Overview

The epidemiology and demographics of alopecia varies by age, race, sex, and health status.

Epidemiology and Demographics

In [year], the incidence/prevalence of [disease name] was estimated to be [number range] cases per 100,000 individuals worldwide.

  • Androgenetic alopecia affects 50% of men and 15% of women, particularly postmenopausal women. [1]
  • In alopecia areata, the prevalence is 0.2% and has no age or sexual predilection. However, it affects white races more than dark races.
  • In telogen effluvium, women are at higher predisposition than men.
  • Tinea capitis has a higher incidence among the pediatric age group and in darker races. [2]
  • Anagen effluvium is more common in cancer patients receiving treatment with chemotherapeutic agents.
  • Traction alopecia is more commonly seen among black populations with females being affected more often than males (31.7% vs 2.3). Traction alopecia was seen in 18% of girls between the ages of 5.4 to 14.3 years based on a study of African-American girls. An 8-month old girl was the youngest reported case in the study. [3]

Prevalence

  • Alopecia areata has a prevalence of about 1 in 1000 people, and risk of about 2% over an individual's life [4] [5]. Alopecia areata can occur in adults and children and distribution is about equal between the sexes [4]. The mean age for diagnosis of alopecia areata is 32 years in males and 36 years in females based on a study of the population of Olmsted County, Minnesota which was done between 1990 to 2009 [6].
  • When using numbers with decimal points, avoid reporting more than 1 number after the decimal point. For example, report a prevalence as 10.1 instead of 10.09322. Many numbers after the decimal point may suggest a false sense of accuracy.
  • You can use one or more of these template sentences.
    • Worldwide, the prevalence of (insert disease state here) ranges from a low of _____ per 100,000 persons to a high of _____ per 100,000 persons with an average prevalence of _____ per 100,000 persons.
    • Worldwide, the prevalence of (insert disease state here) is _____ per 100,000 persons.
    • In developed countries, the prevalence of (insert disease state here) ranges from a low of _____ per 100,000 persons to a high of _____ per 100,000 persons with an average prevalence of _____ per 100,000 persons.
    • In developed countries, the prevalence of (insert disease state here) is _____ per 100,000 persons.
    • In developing countries/ Africa, the prevalence of (insert disease state here) ranges from a low of _____ per 100,000 persons to a high of _____ per 100,000 persons with an average prevalence of _____ per 100,000 persons.
    • In developing countries/ Africa, the prevalence of (insert disease state here) is _____ per 100,000 persons.
    • In ____ (insert year), the prevalence of _______ (insert disease name) was estimated to be _______ (insert number) cases per 100,000 individuals worldwide.

Incidence

  • The overall incidence is approximately 20.2 per 100,000 person-years. [5]
  • The standard format to report the incidence is ___ per 100,000 individuals.
  • When using numbers with decimal points, avoid reporting more than 1 number after the decimal point. For example, report a incidence as 10.1 instead of 10.09322. Many numbers after the decimal point may suggest a false sense of accuracy.
  • You can pick one or more of the template sentences below for this section:
    • Worldwide, the incidence of (insert disease state here) ranges from a low of _____ per 100,000 persons to a high of _____ per 100,000 persons with an average incidence of _____ per 100,000 persons.
    • Worldwide, the incidence of (insert disease state here) is _____ per 100,000 persons.
    • In developed countries, the incidence of (insert disease state here) ranges from a low of _____ per 100,000 persons to a high of _____ per 100,000 persons with an average incidence of _____ per 100,000 persons.
    • In developed countries, the incidence of (insert disease state here) is _____ per 100,000 persons.
    • In developing countries/ Africa, the incidence of (insert disease state here) ranges from a low of _____ per 100,000 persons to a high of _____ per 100,000 persons with an average incidence of _____ per 100,000 persons.
    • In developing countries/ Africa, the incidence of (insert disease state here) is _____ per 100,000 persons.
    • In ____ (insert year), the incidence of _______ (insert disease name) was estimated to be _______ (insert number) cases per 100,000 individuals worldwide.

Case Fatality Rate

  • The case fatality rate is defined the number of deaths (fatality) among patients with the disease (case). Case fatality rate should be distinguished from "Mortality Rate" (defined as the number of deaths among the at-risk population).
  • The case fatality rate is usually described as a function of time (e.g. In 2015 / annually etc...).
  • When using numbers with decimal points, avoid reporting more than 1 number after the decimal point. For example, report the case fatality rate as 10.1% instead of 10.09322%. Many numbers after the decimal point may suggest a false sense of accuracy.
  • You can pick the template sentence below for this section:
    • In ____ (year), the case fatality rate of ____ (disease name) is ____ (case fatality rate in %).
    • The annual case fatality rate of ____ (disease name) is approximately ____ (case fatality rate in %).

Age

  • This section can describe the impact of the disease depending on the persons age, and the age-specific prevalence and incidence.
  • The prevalence of ____ (insert disease state here) increases/decreases with age.
  • _____ (insert acute disease) commonly affects _____ (insert age group).
  • _____ (insert chronic disease) is usually first diagnosed among _____ (insert age group).

Gender

This section describe how prevalence of the disease varies by gender. When describing male to female ratios with decimal points, avoid reporting more than 1 number after the decimal point. For example, report a ratio as as 1.5 to 1 instead of 1.48294 to 1. Many numbers after the decimal point may suggest a false sense of accuracy. You can use either of the following template sentences:

  • ______ (insert gender 1) are more commonly affected with ______ (insert disease name) than _____ (insert gender 2). The _____ (insert gender ratio e.g. male to female) ratio is approximately _____ (insert number > 1) to 1.
  • The prevalence and incidence of (insert disease state here) does not vary by gender.
  • Men and women are affected equally by (insert disease name here).
  • (Insert disease state here) is more prevalent in men women.
  • The prevalence of (insert disease state here) among men is ____ per 100,000, while it is _____ per 100,000 among women.
  • The incidence of (insert disease state here) among men is ____ per 100,000, while it is _____ per 100,000 among women.

Race

This section describes how the disease differs based upon race. You can use the following template sentence for this section:

  • The prevalence of _____ (insert disease) does not vary by race.
  • (Insert disease state here) is more prevalent in the ____ (insert race) race and ____ (insert other race) races.
  • There is no racial predilection for ____ (insert disease name)
  • _____ (insert disease) usually affects individuals of the _____ (insert race) race. _____ (insert other race) individuals are less likely to develop ______ (disease name).

References

  1. Rinaldi F, Marzani B, Pinto D, Sorbellini E (2019). "Randomized controlled trial on a PRP-like cosmetic, biomimetic peptides based, for the treatment of alopecia areata". J Dermatolog Treat. 30 (6): 588–593. doi:10.1080/09546634.2018.1544405. PMID 30513014.
  2. Owczarczyk-Saczonek A, Wygonowska E, Budkiewicz M, Placek W (2019) Serum sickness disease in a patient with alopecia areata and Meniere' disease after PRP procedure. Dermatol Ther 32 (2):e12798. DOI:10.1111/dth.12798 PMID: 30511475
  3. Aguado Lobo M, Jiménez-Reyes J (2018). "Traction alopecia". Int J Dermatol. 57 (2): 231–232. doi:10.1111/ijd.13846. PMID 29265342.
  4. 4.0 4.1 Strazzulla LC, Wang EHC, Avila L, Lo Sicco K, Brinster N, Christiano AM; et al. (2018). "Alopecia areata: Disease characteristics, clinical evaluation, and new perspectives on pathogenesis". J Am Acad Dermatol. 78 (1): 1–12. doi:10.1016/j.jaad.2017.04.1141. PMID 29241771.
  5. 5.0 5.1 Safavi KH, Muller SA, Suman VJ, Moshell AN, Melton LJ (1995). "Incidence of alopecia areata in Olmsted County, Minnesota, 1975 through 1989". Mayo Clin Proc. 70 (7): 628–33. doi:10.4065/70.7.628. PMID 7791384.
  6. Mirzoyev SA, Schrum AG, Davis MDP, Torgerson RR (2014). "Lifetime incidence risk of alopecia areata estimated at 2.1% by Rochester Epidemiology Project, 1990-2009". J Invest Dermatol. 134 (4): 1141–1142. doi:10.1038/jid.2013.464. PMC 3961558. PMID 24202232.

Template:WikiDoc Sources